Share us

Insulin Glargine (DMF available) manufacturered by US FDA approved factory CasNo.: 160337-95-1



Insulin glargine (CAS 160337-95-1) is a long-acting basal insulin analogue, helping control the blood sugar level of those with type 1 and type 2 diabetes mellitus. It is an analogue of human insulin made by replacing the asparagine residue at position A21 of the A-chain with glycine and adding two arginines to the C-terminus (positions B31 and 32) of the B-chain.
Right now, insulin glargine (CAS 160337-95-1) API is commercially available . We are working on its international registration, such as DMF/ CEP/ J-DMF and so on. If you need insulin glargine API with DMF USP grade (CAS 160337-95-1), please kindly contact us via following contact information.

Apino Pharma focuses on phamraceutical industry especially APIs and Key Intermediates as well as full service from R&D stage to commercial stage with the concept of “Added Value, Profession, Innovation”. We strictly follow the principle “Quality First” by supplying most reliable quality, professional service and reasonable price for the customers.

Apino supply below featured products and professional service:
1.APIs (Mainly new generic APIs and Biosimilar products-Peptides, Anti-cancer mabs, Insulin…etc.)
3.Finished products
4.Custom Synthesis Service

Insulin, Insulin glargine,

Read More


Cetuximab 100mg/20ml Injection(Bulk solution can be supplied commercially as well)...

Apino Pharma Co., Ltd.

API, Intermediates, Peptides

Read More


Tel: +8613265879427
413, Jinrun Building, No.6019 Shennan Road, Tianan Community, Shatou Street, Futian District, Shenzhen City, China, Guangdong, China, 518000


H5/响应式/营销型企业网站; 26种语言扩展;
覆盖: 英文、法语、德语、西班牙语、葡萄牙语、俄语、阿拉伯语、波斯语、日语、韩语